Our News on Newswise

Newswise: 62cd879686757_ScreenShot2022-07-12at10.38.04AM.png

Pat Morin Appointed Deputy Scientific Director of the Ludwig Institute for Cancer Research

Ludwig Cancer Research extends a warm welcome to Pat Morin, who has been appointed deputy scientific director of the Ludwig Institute for Cancer Research.
12-Jul-2022 10:05 AM EDT Add to Favorites

Newswise: 627bd5ab1421e_ScreenShot2022-05-11at11.20.30AM.png

Ludwig MSK Study Modeling Tumor Evolution Reveals a Vulnerability for Cancer Prevention and Therapy

Though the mutations accumulated by cancer cells occur more or less randomly, certain regions of genes essential to cancer growth appear to be more frequently mutated than others in established tumors.
11-May-2022 11:05 AM EDT Add to Favorites

Ludwig Cancer Research Scientists to Present Advances in Cancer Research at 2022 AACR Annual Meeting

Ludwig Cancer Research released today the full scope of research to be presented by Ludwig-affiliated scientists at the 2022 American Association for Cancer Research (AACR) Annual Meeting, which will be held online and in person at the Ernest N....
4-Apr-2022 12:05 PM EDT Add to Favorites

Newswise: 622a4c6caecf7_Chris Garcia.jpg

Ludwig Stanford Study Solves Long-Sought Protein Structure, Shows How Mutation Drives Blood Cancers

Researchers led by Christopher Garcia of the Ludwig Center at Stanford University have solved the long-sought structure of a large signaling protein involved in responses to infection, inflammation, the generation of immune cells and—when...
10-Mar-2022 2:25 PM EST Add to Favorites

Newswise: 62068aa574496_Rabinowitz.jpg

Ludwig Princeton Preclinical Study Shows Ketogenic Diet Could Enhance Pancreatic Cancer Therapy

A Ludwig Cancer Research preclinical study has demonstrated that a common weight-loss diet could enhance the efficacy of chemotherapy for pancreatic cancer.
11-Feb-2022 11:40 AM EST Add to Favorites

Newswise: 620144566014d_PrincetonChi.jpg

Ludwig Cancer Research Study Identifies Potential Vulnerability in Drug-Resistant Neuroblastoma

A Ludwig Cancer Research study has identified a potential vulnerability in neuroblastoma tumors that might be exploited to improve treatment of the aggressive childhood cancer, which accounts for roughly 15% of all deaths from pediatric...
7-Feb-2022 12:45 PM EST Add to Favorites

Ludwig Lausanne Team Devises a Method to Selectively Grow Tumor-Targeting T Cells for Cancer Therapy

A Ludwig Cancer Research study has devised a highly efficient method to generate large numbers of immune cells specifically engineered to recognize neoantigens—small fragments of randomly mutated proteins that are typically unique to a patient’s...
15-Nov-2021 11:00 AM EST Add to Favorites

Newswise: CoukosBanner.png

Ludwig Cancer Research Study Identifies Cellular Interactions Essential to the Immune Attack on Ovarian Tumors

A Ludwig Cancer Research study has uncovered a cellular interaction that is essential to the ability of the immune system’s cytotoxic T lymphocytes to destroy ovarian tumors and shown that its engagement could help determine the efficacy of...
5-Nov-2021 4:45 PM EDT Add to Favorites


See All News

Our Experts on Newswise

Our experts are coming soon...

Our YouTube Videos

Youtube feed not yet configured. Is this your Newswise member page? Contact member@newswise.com to configure this module.

About

Ludwig Cancer Research is an international collaborative network of acclaimed scientists that has pioneered cancer discoveries for more than 40 years. Ludwig combines basic research with the ability to translate its discoveries and conduct clinical trials to accelerate the development of new cancer diagnostics and therapies. Since 1971, Ludwig has invested more than $2.5 billion in life-changing cancer research through the not-for-profit Ludwig Institute for Cancer Research and the six U.S.-based Ludwig Centers.

Contacts

Carol Harrison
Senior Partner
cancer medicine

carol@gga.nyc

917-860-9499

Rachel Reinhardt
Vice President for Communications

rreinhardt@lcr.org

Rachel Steinhardt
Vice President for Communications
cancer medicine

rsteinhardt@licr.org

212-450-1582

Our Multimedia on Newswise

Twitter

close
0.14375